1.65
6.45%
0.10
After Hours:
1.70
0.05
+3.03%
Immunic Inc stock is traded at $1.65, with a volume of 365.40K.
It is up +6.45% in the last 24 hours and up +9.27% over the past month.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
See More
Previous Close:
$1.55
Open:
$1.55
24h Volume:
365.40K
Relative Volume:
0.90
Market Cap:
$150.42M
Revenue:
-
Net Income/Loss:
$-93.61M
P/E Ratio:
-0.481
EPS:
-3.43
Net Cash Flow:
$-71.16M
1W Performance:
+3.12%
1M Performance:
+9.27%
6M Performance:
+25.00%
1Y Performance:
+12.24%
Immunic Inc Stock (IMUX) Company Profile
Name
Immunic Inc
Sector
Industry
Phone
(332) 255-9818
Address
1200 AVENUE OF THE AMERICAS, NEW YORK
Immunic Inc Stock (IMUX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-21-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Sep-19-22 | Resumed | H.C. Wainwright | Buy |
Apr-15-21 | Initiated | Aegis Capital | Buy |
Mar-24-21 | Initiated | JMP Securities | Mkt Outperform |
Oct-02-20 | Initiated | SVB Leerink | Outperform |
Aug-26-20 | Initiated | Piper Sandler | Overweight |
Aug-07-20 | Resumed | ROTH Capital | Buy |
Jul-20-20 | Initiated | BMO Capital Markets | Outperform |
Jun-05-20 | Initiated | Wedbush | Outperform |
May-11-20 | Initiated | H.C. Wainwright | Buy |
Mar-25-20 | Initiated | ROTH Capital | Buy |
Jul-11-19 | Initiated | Chardan Capital Markets | Buy |
View All
Immunic Inc Stock (IMUX) Latest News
Immunic CMO on key ECTRIMS highlights and MS research - Proactive Investors USA
Get in on Immunic Inc’s (IMUX) buy-in window today! - SETE News
IMUX’s 2023 Market Saga: Unraveling the Story of Gains and Losses - The InvestChronicle
Market Momentum Report: Immunic Inc (IMUX)’s Negative Close at 1.60 - The Dwinnex
Analysts review Immunome Inc’s rating - Knox Daily
Immunome (NASDAQ:IMNM) Shares Down 5.6% After Insider Selling - MarketBeat
IMAX (NYSE:IMAX) Stock Price Down 4.9% - Defense World
Ratio Review: Analyzing Imunon Inc (IMNN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
IMAX Co. (NYSE:IMAX) Shares Sold by Rhumbline Advisers - Defense World
What is the investor’s view on Immunic Inc (IMUX)? - US Post News
Immuneering Corp Inc. (IMRX) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
Hancock Whitney Corp Sells 2,958 Shares of Polaris Inc. (NYSE:PII) - Defense World
You might want to take a look at Inuvo Inc (INUV) now - SETE News
Imunon Inc (IMNN) may enjoy gains as insiders got busy in the recent days - Knox Daily
Applied Fundamental Research LLC Decreases Stock Holdings in UFP Technologies, Inc. (NASDAQ:UFPT) - MarketBeat
UniQure rises on orphan drug status for genetic disorder gene therapy - XM
uniQure Gains FDA Orphan Drug Status for Fabry Disease Therapy - TipRanks
UFP Industries, Inc. (NASDAQ:UFPI) Holdings Decreased by Seven Eight Capital LP - Defense World
Unichem Laboratories Set To Discuss US Business Consolidation At Upcoming Board Meeting - NDTV Profit
Are Immuneering Corp (IMRX) shares a good deal now? - US Post News
Itau Unibanco Holding S.A. Acquires New Position in Incyte Co. (NASDAQ:INCY) - Defense World
IPCA Laboratories Looking to Consolidate US Generics Business; Shares Gain - EquityPandit
Unichem Labs plans to consolidate US generic formulations bizz - Indiainfoline
Ipca Laboratories to Consolidate US Generics Business; Shares Up 1% - Indiainfoline
Victory Capital Management Inc. Has $611,000 Stake in Urban Outfitters, Inc. (NASDAQ:URBN) - Defense World
Unichem Labs Eyes US Market Consolidation - Devdiscourse
Immatics (IMTX): Short Seller Sentiment is Bearish On This ADR Stock - Insider Monkey
Ipca Laboratories to consider consolidaton of US generics business - CNBCTV18
Unichem Labs gains on proposal to consolidate USA generics formulations business under one entity - Business Standard
Itau Unibanco Holding S.A. Trims Stock Holdings in Micron Technology, Inc. (NASDAQ:MU) - Defense World
Itau Unibanco Holding S.A. Purchases New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
Integrated BioPharma (OTCMKTS:INBP) Posts Quarterly Earnings Results - Defense World
Renaissance Technologies LLC Has $15.14 Million Holdings in UFP Industries, Inc. (NASDAQ:UFPI) - Defense World
Mutual of America Capital Management LLC Sells 952 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
Micron Technology, Inc. (NASDAQ:MU) Shares Sold by Itau Unibanco Holding S.A. - MarketBeat
Inspire Investing LLC Decreases Stock Holdings in UFP Technologies, Inc. (NASDAQ:UFPT) - Defense World
Acadian Asset Management LLC Has $61,000 Holdings in IMAX Co. (NYSE:IMAX) - Defense World
Max Rosett Sells 14,380 Shares of Immunome, Inc. (NASDAQ:IMNM) Stock - MarketBeat
ImmunityBio: Anktiva Launch, Good Data, Low Cash, High Debt (NASDAQ:IBRX) - Seeking Alpha
MQS Management LLC Buys Shares of 3,973 Polaris Inc. (NYSE:PII) - Defense World
Immunome, Inc. (NASDAQ:IMNM) CFO Max Rosett Sells 14,380 Shares - Defense World
Urban Outfitters (NASDAQ:URBN) Upgraded at StockNews.com - MarketBeat
Immunome CFO sells shares valued at over $230,000 - Investing.com
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 - StockTitan
MS Aubagio tableau: Sanofi talks tolebrutinib, Immunic the pick? - BioWorld Online
Why Is Urban Outfitters (URBN) Up 0% Since Last Earnings Report? - Yahoo Finance
Ieq Capital LLC Has $148.19 Million Stake in Upbound Group, Inc. (NASDAQ:UPBD) - MarketBeat
Choreo LLC Buys Shares of 1,975 UFP Industries, Inc. (NASDAQ:UFPI) - Defense World
Commonwealth Equity Services LLC Sells 583 Shares of UFP Industries, Inc. (NASDAQ:UFPI) - Defense World
Just the Facts: Imugene receives Orphan Drug Designation for VAXINIA from FDA - Proactive Investors Australia
Why Uxin Stock Was Skyrocketing Today - AOL
Immunic Inc Stock (IMUX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):